Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
EnsaliX is a generative AI tool for the Saudi national start-up biotechnology company Nanopalm that creates next generation nanomedicines for affordable and accelerated pharmaceutical R&D activities. Founded in 2022, and headquartered in Riyadh, NanoPalm is a spinoff from KACST and partner-backed.
EnsaliX's main goal is to accelerate clinical trials in a cost-effective manner. Utilizing our next generation lipid nanoparticles (NG-LNP), we aim to develop effective Biorobots that ensure the success of drugs in gene therapy and clinical trials.
If you're interested to invest, start by applying here.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.